Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kerr

Showing results (41-50 of 315) with videos related to

Pageof 32
Sort By:
Diabetes Technology & Therapeutics|June 3, 2010
Pascal's wager: combining continuous glucose monitoring and continuous subcutaneous insulin infusionDavid Kerr, Tolu Olateju
The Lancet. Diabetes & Endocrinology|July 4, 2021
Principles for virtual health care to deliver real equity in diabetesDavid Kerr, Ashutosh Sabharwal
BMJ (Clinical Research Ed.)|April 20, 2002
Fifth revision of Declaration of Helsinki. Clause 29 forbids trials from using placebos when effective treatment existsJ M Bland, David Kerr
Journal of Diabetes Science and Technology|September 6, 2018
Digital Diabetes Data and Artificial Intelligence: A Time for Humility Not HubrisDavid Kerr, David C Klonoff
Journal of Diabetes Science and Technology|July 29, 2016
Digital Diabetes Communication: There's an App for ThatDavid C Klonoff, David Kerr
The Lancet. Diabetes & Endocrinology|February 9, 2025
What is a normal glucose value?Viral N Shah, David Kerr
Journal of Diabetes Science and Technology|October 4, 2017
Overcoming Barriers to Adoption of Digital Health Tools for DiabetesDavid C Klonoff, David Kerr
Journal of Diabetes Science and Technology|September 9, 2017
A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose MonitoringDavid C Klonoff, David Kerr
Journal of Diabetes Science and Technology|February 8, 2018
Smart Pens Will Improve Insulin TherapyDavid C Klonoff, David Kerr
Oncotarget|September 22, 2018
Prognostic markers for colorectal cancerHelen E J Tyrrell, David Kerr
Pageof 32

Showing results (41-50 of 315) with videos related to

Sort By:
Pageof 32
Diabetes Technology & Therapeutics|June 3, 2010
Pascal's wager: combining continuous glucose monitoring and continuous subcutaneous insulin infusionDavid Kerr, Tolu Olateju
The Lancet. Diabetes & Endocrinology|July 4, 2021
Principles for virtual health care to deliver real equity in diabetesDavid Kerr, Ashutosh Sabharwal
BMJ (Clinical Research Ed.)|April 20, 2002
Fifth revision of Declaration of Helsinki. Clause 29 forbids trials from using placebos when effective treatment existsJ M Bland, David Kerr
Journal of Diabetes Science and Technology|September 6, 2018
Digital Diabetes Data and Artificial Intelligence: A Time for Humility Not HubrisDavid Kerr, David C Klonoff
Journal of Diabetes Science and Technology|July 29, 2016
Digital Diabetes Communication: There's an App for ThatDavid C Klonoff, David Kerr
The Lancet. Diabetes & Endocrinology|February 9, 2025
What is a normal glucose value?Viral N Shah, David Kerr
Journal of Diabetes Science and Technology|October 4, 2017
Overcoming Barriers to Adoption of Digital Health Tools for DiabetesDavid C Klonoff, David Kerr
Journal of Diabetes Science and Technology|September 9, 2017
A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose MonitoringDavid C Klonoff, David Kerr
Journal of Diabetes Science and Technology|February 8, 2018
Smart Pens Will Improve Insulin TherapyDavid C Klonoff, David Kerr
Oncotarget|September 22, 2018
Prognostic markers for colorectal cancerHelen E J Tyrrell, David Kerr
Pageof 32